Leadership Team

The Leadership Team at Glycomine is responsible for setting the strategic direction and overseeing the development of innovative orphan drugs targeting rare metabolic disorders. Comprising key executives such as the Chief Technology Officer and Chief Scientific Officer, this team collaborates to drive research initiatives, foster partnerships, and ensure that the company's scientific and business strategies align to meet unmet medical needs effectively.